⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31225133 | 1.00 | — | — | |
| SCHEMBL75738 | 1.00 | — | — | |
| SCHEMBL489083 | 1.00 | — | — | |
| SCHEMBL31266879 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL238775 | 0.97 | — | — | |
| Potassium SCHEMBL31266896 | 0.97 | — | — | |
| SCHEMBL5698765 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL902194 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL238776 | 0.97 | — | — | |
| Bromide SCHEMBL489645 | 0.97 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1482 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119020865-B | Chiral halide perovskite single crystal and preparation method and application thereof | 暨南大学 | 2025-05-06 | — | — | CN | claimed |
| CN-119020865-A | Chiral halide perovskite single crystal and preparation method and application thereof | 暨南大学 | 2024-11-26 | — | — | CN | claimed |
| CN-114671989-B | Chiral covalent organic framework material, preparation method and application | 山东师范大学 | 2024-05-28 | — | — | CN | claimed |
| CN-116814574-A | Imine reductase mutant, recombinant genetically engineered bacterium and application thereof in (R) -2-methylpyrrolidine synthesis | 华东理工大学 | 2023-09-29 | — | — | CN | claimed |
| CN-114805832-B | Chiral covalent organic framework photocatalyst containing transition metal and preparation method thereof | 复旦大学 | 2023-03-10 | — | — | CN | claimed |
| CN-115304729-A | High-crystallinity chiral two-dimensional covalent organic framework material and preparation method thereof | 中国科学院化学研究所 | 2022-11-08 | — | — | CN | claimed |
| CN-114805832-A | Chiral covalent organic framework photocatalyst containing transition metal and preparation method thereof | 复旦大学 | 2022-07-29 | — | — | CN | claimed |
| CN-114671989-A | Chiral covalent organic framework material, preparation method and application | 山东师范大学 | 2022-06-28 | — | — | CN | claimed |
| EP-3067355-B1 | CRYSTALS OF DIAZABICYCLOOCTANE DERIVATIVE AND PRODUCTION METHOD FOR CRYSTALS OF DIAZABICYCLOOCTANE DERIVATIVE | MEIJI SEIKA PHARMA CO LTD (JP) | 2020-12-16 | — | — | EP | claimed |
| CN-111747950-A | Pyrimidine derivatives for the treatment of cancer | 深圳福沃药业有限公司 | 2020-10-09 | — | — | CN | claimed |
| JP-2006525296-A | — | — | 2006-11-09 | — | — | JP | claimed |
| US-20060211714-A1 | Quinazoline derivatives and their use in the treatment of cancer | ASTRAZENECA AB (SE) | 2006-09-21 | — | — | US | claimed |
| US-7098222-B2 | Bicyclic-substituted amines having cyclic-substituted monocyclic substituents | ABBOTT LABORATORIES (US) | 2006-08-29 | — | — | US | claimed |
| EP-1622620-A1 | QUINAZOLINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CANCER | AstraZeneca AB (SE) | 2006-02-08 | — | — | EP | claimed |
| US-20050272728-A1 | Bicyclic-substituted amines having cyclic-substituted monocyclic substituents | ABBVIE INC. | 2005-12-08 | — | — | US | claimed |
| WO-2005113551-A1 | BICYCLIC-SUBSTITUTED AMINES HAVING CYCLIC-SUBSTITUTED MONOCYCLIC SUBSTITUENTS | ABBOTT LABORATORIES (US) | 2005-12-01 | — | — | WO | claimed |
| US-20050256127-A1 | 2-(6-{2-[(2R)-2-methyl-1-pyrrolidin-1-yl]-ethyl}-2-naphthalen-2-yl)-2H-pyridazin-3-one salts and their preparation | ABBVIE INC. | 2005-11-17 | — | — | US | claimed |
| US-20050256118-A1 | Bicyclic-substituted amines having cyclic-substituted monocyclic substituents | ABBOTT LABORATORIES | 2005-11-17 | — | — | US | claimed |
| WO-2004096226-A1 | QUINAZOLINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CANCER | ASTRAZENECA AB (SE) | 2004-11-11 | — | — | WO | claimed |
| US-20040054185-A1 | Process for preparing amine-substituted benzofurans | COWART MARLON D (US) | 2004-03-18 | — | — | US | claimed |